🔎 Trials Near Me

Pradžia › Šizofrenija › Ilinoisas › Chicago

Šizofrenija klinikiniai tyrimai Chicago, IL

Vienas tyrimas dėl Šizofrenija ieško dalyvių vietoje Chicago arba jos apylinkėse. Atidarykite jį, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

Renkami dalyviaiLaukiami sveiki savanoriai
  • The University of Chicago, Chicago
Amžius nuo 18 iki 59 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07853807

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Renkami dalyviai1 fazė
  • Uptown Research Institute, Chicago
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Renkami dalyviai3 fazė
  • Local Institution - 0067, Chicago
  • Pillar Clinical Research -Chicago, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07686263

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Renkami dalyviai3 fazė
  • Neurocrine Clinical Site, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07114874

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Renkami dalyviai3 fazė
  • Local Institution - 0175, Chicago
  • EmVenio Research Center - Prime Healthcare, Chicago
Amžius nuo 5 iki 17 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

Renkami dalyviai2 fazė
  • Re:Cognition Health - Chicago, Chicago
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07410507

52-week Open Label Safety-Tolerability Study

Renkami dalyviai3 fazė
  • Pillar Clinical Research, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Renkami dalyviai3 fazė
  • Local Institution - 0122, Chicago
  • EmVenio Research Center - Prime Healthcare, Chicago
Amžius nuo 13 iki 17 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Renkami dalyviai1 fazė
  • Uptown Research Institute, Chicago
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Renkami dalyviai2 fazė
  • Clinical Site, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Renkami dalyviai3 fazė
  • Alkermes Investigator Site, Chicago
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-08-14 · NCT05303064

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

Renkami dalyviai2 fazė
  • Uptown Research Institute LLC, Chicago
  • Pillar Clinical Research LLC, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-29 · NCT07467993

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Renkami dalyviai3 fazė
  • Pillar Clinical Research, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-27 · NCT07363577

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Renkami dalyviai2 fazė
  • Uptown Research Institute, Chicago
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07191483

A Study to Evaluate the Effect of KarXT on Urological Safety

Renkami dalyviai4 fazė
  • Uptown Research Institute, Chicago
  • Pillar Clinical Research -Chicago, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-03 · NCT07221877

CLOZAPINE Response in Biotype-1

Renkami dalyviai4 fazė
  • University of Chicago, Chicago
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-05-11 · NCT04580134

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Renkami dalyviaiStebimasis tyrimas
  • University of Chicago Medical Center, Chicago
Amžius nuo 18 iki 40 · Visoms lytims · Atnaujinta 2026-03-10 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Renkami dalyviai3 fazė
  • Neurocrine Clinical Site, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-03-06 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

Renkami dalyviai3 fazė
  • Vanda Investigational Site, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-01-12 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

Renkami dalyviai2 fazė
  • Site 5056, Chicago
Amžius nuo 21 iki 55 · Visoms lytims · Atnaujinta 2025-12-26 · NCT06502964

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Renkami dalyviai3 fazėLaukiami sveiki savanoriai
  • Reviva site, Chicago
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2024-12-19 · NCT05184335

Šizofrenija tyrimai kituose miestuose

Kiti tyrimai Chicago

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.